Effects of ABO Blood Types on the Survival and Marginal Bone Resorption of Dental Implants

NCT04054271 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 963

Last updated 2019-08-13

No results posted yet for this study

Summary

This study evaluates implant survival and marginal bone resorption in patients receiving implant treatment with respect to demographic data and AB0 (groups) blood types.

Conditions

  • Implant Tissue Failure

Sponsors & Collaborators

  • Yuzuncu Yıl University

    lead OTHER

Eligibility

Min Age
19 Years
Max Age
78 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-12-15
Primary Completion
2018-12-15
Completion
2018-12-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04054271 on ClinicalTrials.gov